Arylsulfonyl benzyl ethers as 5-HT2A antagonists

Details for Australian Patent Application No. 2006224336 (hide)

Owner Merck Sharp & Dohme Limited

Inventors Chambers, Mark Stuart; Gilligan, Myra; Humphries, Alexander Charles; Merchant, Kevin John

Agent Spruson & Ferguson

Pub. Number AU-A-2006224336

PCT Pub. Number WO2006/097766

Priority 0505437.4 17.03.05 GB

Filing date 8 March 2006

Wipo publication date 21 September 2006

International Classifications

A61K 31/10 (2006.01)

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/277 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4184 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07C 317/14 (2006.01) Sulfones

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/80 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/097766 Priority application(s): WO2006/097766

25 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224338-Treatment of intestinal conditions by a compound which causes RNA interference

2006224334-Mecano growth factor peptides and their use